Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
Status:
Not yet recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled, multicenter clinical study.
The main purpose of this study was to confirm the efficacy and safety of pirfenidone capsules
in the treatment of pneumoconiosis.